JUNSHI BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: INSIDE INFORMATION -RECEIPT OF A POSITIVE OPINION FROM THE COMMITTEE FORMEDICINAL PRODUCTS FOR HUMAN USE OFTHE EUROPEAN MEDICINES AGENCY FOR TORIPALIMAB
JUNSHI BIO: VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE SUPPLEMENTAL NEW DRUG APPLICATION FOR TORIPALIMAB IN COMBINATION WITH BEVACIZUMAB FOR THE FIRST-LINE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: VOLUNTARY ANNOUNCEMENT - WHOLLY-OWNED SUBSIDIARY OBTAINING THE EU GMP CERTIFICATE
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: VOLUNTARY ANNOUNCEMENT - JS125 RECEIVED THE ACCEPTANCE NOTICE FOR THE INVESTIGATIONAL NEW DRUG APPLICATION
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: VOLUNTARY ANNOUNCEMENT -APPROVAL OF THE SUPPLEMENTAL NEW DRUG APPLICATION FORTORIPALIMAB FOR THEFIRST-LINE TREATMENT OF ADVANCED TNBC
JUNSHI BIO: ELECTION OF THE FOURTH SESSION OFTHE BOARD OF DIRECTORS AND THE BOARD OF SUPERVISORSRETIREMENT OF NON-EXECUTIVE DIRECTORAND INDEPENDENT NON-EXECUTIVE DIRECTORSAPPOINTMENT OF EMPLOYEE REPRESENTATIVE SUPERVISOR
JUNSHI BIO: ARTICLES OF ASSOCIATION
JUNSHI BIO: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
JUNSHI BIO: OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI JUNSHI BIOSCIENCES CO., LTD.*ANNOUNCEMENT ON ELECTION OF CHAIRMAN OF THE BOARDOF DIRECTORS, VICE CHAIRMAN OF THE BOARD OFDIRECTORS, MEMBERS OF SPECIAL COMMITTEES UNDER THEBOARD OF DIRECTORS, CHAIRMAN OF THE B
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: Next Day Disclosure Return
No Data